Open Payments

YORK HOSPITAL

Type
Teaching hospital
Where
YORK, PA
Medicare CCN
390046
Received
$445,830 in 336 records, 2019 ($119,907 general, $325,922 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2019General payment38$119,907
2019Research payment298$325,922

By company

CompanyRecordsAmountYears
Edwards Lifesciences Corporation27$173,3252019
Stryker Corporation24$100,2552019
GW Research Limited7$57,0332019
Boehringer Ingelheim Pharma GmbH & Co.KG7$27,9552019
Boehringer Ingelheim International GmbH165$18,2292019
Merck Sharp & Dohme LLC7$13,2002019
Pharmacyclics LLC, an AbbVie Company69$10,8502019
TriReme Medical LLC4$10,7502019
Incyte Corporation2$8,6902019
Medical Device Business Services, Inc.2$7,3752019
Boston Scientific Corporation6$4,7882019
KARL STORZ Endoscopy-America3$3,2402019
Bolton Medical Inc4$2,1002019
Abbott Laboratories3$2,1002019
Medline Industries LP1$2,0002019
Masimo Corporation2$1,7662019
Zimmer Biomet Holdings, Inc.1$1,3002019
Amgen Inc.1$5002019
Olympus America Inc.1$3702019

By nature of payment

NatureRecordsAmount
Research payment298$325,922
Gift11$98,335
Grant5$10,475
Compensation for services other than consulting, including serving as faculty or as a speaker at a v16$5,159
Education3$2,137
Charitable Contribution1$2,000
Space rental or facility fees (teaching hospital only)2$1,800

Records

DateCompanyAmountNatureFormProductStudyYear
2019-12-31Stryker Corporation$16,451GiftIn-kind items and servicesISOFLEX SE Device, PATIENT HANDLING - PH2019
2019-12-31Stryker Corporation$16,185GiftIn-kind items and servicesISOFLEX SE Device, PATIENT HANDLING - PH2019
2019-12-31Stryker Corporation$16,185GiftIn-kind items and servicesISOFLEX SE Device, PATIENT HANDLING - PH2019
2019-12-31Stryker Corporation$16,185GiftIn-kind items and servicesISOFLEX SE Device, PATIENT HANDLING - PH2019
2019-12-31Stryker Corporation$7,614GiftIn-kind items and servicesISOFLEX LAL Device, PATIENT CARE - PC2019
2019-12-31Stryker Corporation$7,491GiftIn-kind items and servicesISOFLEX LAL Device, PATIENT CARE - PC2019
2019-12-31Stryker Corporation$7,491GiftIn-kind items and servicesISOFLEX LAL Device, PATIENT CARE - PC2019
2019-12-31Stryker Corporation$7,491GiftIn-kind items and servicesISOFLEX LAL Device, PATIENT CARE - PC2019
2019-12-31Boehringer Ingelheim Pharma GmbH & Co.KG$5,591Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-12-31Boehringer Ingelheim Pharma GmbH & Co.KG$3,049Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-12-31Masimo Corporation$1,742EducationIn-kind items and servicesSET and rainbow SET Device, Devices2019
2019-12-19Edwards Lifesciences Corporation$22,035Research paymentCash or cash equivalentPARTNER3 2015-082019
2019-12-16Edwards Lifesciences Corporation$6,969Research paymentCash or cash equivalentEarly-TAVR Trial 2016-072019
2019-12-13GW Research Limited$6,837Research paymentCash or cash equivalentGWEP14152019
2019-12-11Edwards Lifesciences Corporation$4,011Research paymentCash or cash equivalentPARTNER3 2015-082019
2019-12-11Abbott Laboratories$900Space rental or facility fees (teaching hospital only)Cash or cash equivalentXience V coronary stent system Device, Vascular2019
2019-12-11Boehringer Ingelheim International GmbH$858Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-12-10Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-12-10Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-12-10Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-12-10Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-12-10Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-12-10Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-12-06GW Research Limited$4,426Research paymentCash or cash equivalentGWEP15212019
2019-12-06Boehringer Ingelheim International GmbH$52Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-12-03Boehringer Ingelheim International GmbH$858Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-12-03Boehringer Ingelheim International GmbH$831Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-12-03Bolton Medical Inc$550Research paymentCash or cash equivalentTreovance Phase II Trial DeviceTreovance Phase II Trial2019
2019-12-03Bolton Medical Inc$550Research paymentCash or cash equivalentTreovance Phase II Trial DeviceTreovance Phase II Trial2019
2019-12-03Bolton Medical Inc$500Research paymentCash or cash equivalentTreovance Phase II Trial DeviceTreovance Phase II Trial2019
2019-11-29Edwards Lifesciences Corporation$5,803Research paymentCash or cash equivalentPartner3 2015-082019
2019-11-21GW Research Limited$40,604Research paymentCash or cash equivalentGWEP14152019
2019-11-18Boehringer Ingelheim International GmbH$336Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-13TriReme Medical LLC$500Research paymentCash or cash equivalentBALLOON CATHETER Device, BALLOON CATHETERBALLOON CATHETER2019
2019-11-12Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-11-12Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-11-12Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-11-12Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-11-12Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-11-12Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-11-12Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-11-12Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-11-12Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-11-04Boehringer Ingelheim International GmbH$53Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-11-04Boehringer Ingelheim International GmbH$52Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-11-04Boehringer Ingelheim International GmbH$41Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-11-04Boehringer Ingelheim International GmbH$31Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$31Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$26Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-11-04Boehringer Ingelheim International GmbH$24Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-11-04Boehringer Ingelheim International GmbH$23Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-11-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-11-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-11-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$17Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-11-04Boehringer Ingelheim International GmbH$13Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-11-01Medical Device Business Services, Inc.$3,375GrantCash or cash equivalent2019
2019-10-31Boehringer Ingelheim Pharma GmbH & Co.KG$3,049Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-10-31Boehringer Ingelheim Pharma GmbH & Co.KG$3,049Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-10-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-10-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-10-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-10-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-10-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-10-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-10-18Edwards Lifesciences Corporation$6,600Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPARTNER II 2010-122019
2019-10-17Edwards Lifesciences Corporation$14,803Research paymentCash or cash equivalentEarly-TAVR Trial 2016-072019
2019-10-09Stryker Corporation$1,113Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-10-09Stryker Corporation$278Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-10-09Stryker Corporation$101Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-10-09Stryker Corporation$27Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-10-02Boehringer Ingelheim International GmbH$831Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-10-02Boehringer Ingelheim International GmbH$81Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-10-02Boehringer Ingelheim International GmbH$29Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-09-25Boston Scientific Corporation$900GrantCash or cash equivalentGENERAL - STRUCTURAL HEART Device, STRUCTURAL HEART2019
2019-09-23Edwards Lifesciences Corporation$4,570Research paymentCash or cash equivalentPartner3 2015-082019
2019-09-18Edwards Lifesciences Corporation$1,014Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesEarly-TAVR Trial 2016-072019
2019-09-18Edwards Lifesciences Corporation$900Space rental or facility fees (teaching hospital only)Cash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves2019
2019-09-18Boston Scientific Corporation$900GrantCash or cash equivalentGENERAL - THERAPIES Device, THERAPIES2019
2019-09-13Boston Scientific Corporation$638Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2019
2019-09-11Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-09-11Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-09-11Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-09-11Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-09-10Boehringer Ingelheim International GmbH$81Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-09-04Edwards Lifesciences Corporation$1,214Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPARTNER3 2015-082019
2019-09-04Edwards Lifesciences Corporation$200Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPARTNER3 2015-082019
2019-09-04Boehringer Ingelheim International GmbH$23Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-09-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-09-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-09-04Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-08-31Boehringer Ingelheim Pharma GmbH & Co.KG$2,541Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-30Edwards Lifesciences Corporation$1,014Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPARTNER3 2015-082019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-22Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-08-21Edwards Lifesciences Corporation$500Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPARTNER3 2015-082019
2019-08-09GW Research Limited$300Research paymentCash or cash equivalentGWEP14152019
2019-08-05Boehringer Ingelheim International GmbH$81Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-08-02Boehringer Ingelheim International GmbH$41Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$30Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$30Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$30Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-08-02Boehringer Ingelheim International GmbH$30Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$26Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$26Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$25Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$25Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-08-02Boehringer Ingelheim International GmbH$24Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-08-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-08-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-08-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$12Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-08-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-08-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-08-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-31Edwards Lifesciences Corporation$1,014Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesEarly-TAVR Trial 2016-072019
2019-07-29Edwards Lifesciences Corporation$226Research paymentCash or cash equivalentPARTNER II 2010-122019
2019-07-29Edwards Lifesciences Corporation$132Research paymentCash or cash equivalentPARTNER II 2010-122019
2019-07-25Boehringer Ingelheim International GmbH$52Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-23Boehringer Ingelheim International GmbH$52Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-23Boehringer Ingelheim International GmbH$52Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-23Boehringer Ingelheim International GmbH$52Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-23Boehringer Ingelheim International GmbH$17Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-19Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-07-19Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-07-19Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-07-19Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-07-17Edwards Lifesciences Corporation$1,169Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesPARTNER II 2010-122019
2019-07-16KARL STORZ Endoscopy-America$1,230GiftIn-kind items and servicesCORD,HIGH FREQUENCY,BIPOLAR. Device, OTHER MISC2019
2019-07-16Stryker Corporation$758Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-07-16Stryker Corporation$246Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-07-16Stryker Corporation$95Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-07-16Stryker Corporation$19Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREPROCESSED DEVICE Device, HYGIA HEALTH SERVICES2019
2019-07-11Edwards Lifesciences Corporation$12,369Research paymentCash or cash equivalentPartner3 2015-082019
2019-07-08Boehringer Ingelheim International GmbH$858Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-08Boehringer Ingelheim International GmbH$785Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-08Boehringer Ingelheim International GmbH$81Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-02Zimmer Biomet Holdings, Inc.$1,300GrantCash or cash equivalent2019
2019-07-02Abbott Laboratories$500Research paymentCash or cash equivalentABSORB Device, VascularA Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects2019
2019-07-02Boehringer Ingelheim International GmbH$62Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-07-02Boehringer Ingelheim International GmbH$31Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-02Boehringer Ingelheim International GmbH$31Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-02Boehringer Ingelheim International GmbH$26Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-02Boehringer Ingelheim International GmbH$15Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-07-02Boehringer Ingelheim International GmbH$15Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-02Boehringer Ingelheim International GmbH$13Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-07-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-02Boehringer Ingelheim International GmbH$10Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-07-02Boehringer Ingelheim International GmbH$7Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-06-24Edwards Lifesciences Corporation$70,568Research paymentCash or cash equivalentPARTNER3 2015-082019
2019-06-21Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-06-21Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-06-21Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-06-14Boston Scientific Corporation$1,025Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2019
2019-06-13Boehringer Ingelheim International GmbH$141Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-06-13Boehringer Ingelheim International GmbH$59Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-06-13Boehringer Ingelheim International GmbH$17Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-06-12Boehringer Ingelheim International GmbH$796Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-06-12Boehringer Ingelheim International GmbH$724Research paymentCash or cash equivalentJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-06-07Abbott Laboratories$700Research paymentCash or cash equivalentABSORB Device, VascularA Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects2019
2019-06-07Bolton Medical Inc$500Research paymentCash or cash equivalentTreovance Phase II Trial DeviceTreovance Phase II Trial2019
2019-06-07Merck Sharp & Dohme LLC$300Research paymentCash or cash equivalentMK-0859 Drug, CARDIOVASCULARHPS 3 , TIMI 55 REVEAL Randomized EValuation of the Effects of Anacetrapib through Lipid-modification A large-scale, ran2019
2019-06-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-06-04Boehringer Ingelheim International GmbH$20Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-06-04Boehringer Ingelheim International GmbH$0Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and heart failure (HFpEF)2019
2019-06-03TriReme Medical LLC$250Research paymentCash or cash equivalentBALLOON CATHETER Device, BALLOON CATHETERBALLOON CATHETER2019
2019-05-31Boehringer Ingelheim Pharma GmbH & Co.KG$6,099Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESEmpagliflozin and Heart failure (HFrEF)2019
2019-05-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-05-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-05-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-05-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-05-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-05-20Pharmacyclics LLC, an AbbVie Company$150Research paymentCash or cash equivalentIbrutinib Drug, OncologyPCYC-1134M-CA2019
2019-05-17KARL STORZ Endoscopy-America$1,950GiftIn-kind items and servicesSCISSORS,HORIZ CUT,RIGHT,SNGL Device, GYNECOLOGY2019

The latest 200 records of 336.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

York CountyYork city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In York, PA, county York County, PA, state Pennsylvania; placed by its city name.

MeasurePlace (city or town)
York, PA
County
York County, PA
State
Pennsylvania
Population B0100344,938462,92413,018,639
Population, 2020 census P144,800456,43813,002,700
Median age B0100234.341.140.9
Under 18 B0100123.9%21.9%20.4%
65 and over B0100113.1%18.8%19.5%
Households B1100117,893181,5835,274,853
Foreign born B0500211.1%4.1%7.7%
Median household income B19013$48,420$84,829$77,971
Median family income B19113$54,727$102,186$100,262
Per capita income B19301$26,308$41,601$44,355
Poverty rate B1700121.1%8.4%11.7%
Unemployment rate B2302510.7%4.5%5.3%
Civilian labor force B2302523,179245,6936,684,175
Mean commute (minutes) B0801323.126.326.3
Bachelor's degree or higher B1500317.5%27.6%35.2%
Housing units B2500119,505189,8575,806,452
Owner-occupied B2500343.7%76.3%69.3%
Renters B2500356.3%23.7%30.7%
Median home value B25077$119,700$248,600$254,500
Median gross rent B25064$1,014$1,193$1,209
White, not Hispanic B0300233.6%78.9%73.0%
Black B0300224.1%5.8%10.3%
Hispanic or Latino B0300236.6%9.6%8.7%
Asian B030021.0%1.5%3.8%
American Indian and Alaska Native B030020.0%0.0%0.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in York, PA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.